Repeat botulinum toxin-A injections in the upper limb of children with hemiplegia: A randomized controlled trial

Developmental Medicine and Child Neurology

Volumn 52, Issue 1, 2010, Pages 79-86

  Olesch, Christine A ^a   Greaves, Susan ^a   Imms, Christine ^b   Reid, Susan M ^b   Graham, H Kerr ^a  

^a ROYAL CHILDREN'S HOSPITAL   (Australia)

^b MURDOCH CHILDREN'S RESEARCH INSTITUTE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

BOTULINUM TOXIN A;

ARM MOVEMENT; ARM MUSCLE; ARTICLE; BICEPS BRACHII MUSCLE; CEREBRAL PALSY; CHILD; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE CLASSIFICATION; DRUG EFFICACY; FEMALE; FLEXOR MUSCLE; HEMIPLEGIA; HUMAN; INTERMETHOD COMPARISON; MACULOPAPULAR RASH; MALE; MOTOR PERFORMANCE; MULTIPLE CYCLE TREATMENT; OCCUPATIONAL THERAPY; OUTCOME ASSESSMENT; PARENTAL BEHAVIOR; PRESCHOOL CHILD; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RATING SCALE; SCORING SYSTEM; SPASTICITY; TREATMENT DURATION; TREATMENT OUTCOME; WEAKNESS;

ARM; BOTULINUM TOXIN TYPE A; CEREBRAL PALSY; CHILD, PRESCHOOL; COMBINED MODALITY THERAPY; FEMALE; HEMIPLEGIA; HUMANS; INFANT; INJECTIONS, INTRAMUSCULAR; MALE; OCCUPATIONAL THERAPY; PSYCHOMOTOR PERFORMANCE; RETREATMENT; TREATMENT OUTCOME; VICTORIA;

EID: 73249134343     PISSN: 00121622     EISSN: 14698749     Source Type: Journal    
DOI: 10.1111/j.1469-8749.2009.03387.x     Document Type: Article

References (31)

1. Stanley F, Blair E, Alberman E. Cerebral Palsies: Epidemiology and Causal Pathways 2000, Clinics in Developmental Medicine No. 151. London, UK, Mac Keith Press
2. Howard J, Soo B, Graham HK. Cerebral palsy in Victoria: motor types, topography and gross motor function. J Paediatr Child Health 2005, 41:479-83.
3. Hoare BJ, Imms C. Upper-limb injections of botulinum toxin-A in children with cerebral palsy: a critical review of the literature and clinical implications for occupational therapists. Am J Occup Ther 2004, 58:389-97.
4. Lowe K, Novak I, Cusick A. Low-dose/high-concentration localized botulinum toxin A improves upper limb movement and function in children with hemiplegic cerebral palsy. Dev Med Child Neurol 2006, 48:170-75.
5. Wallen M, O'Flaherty SJ, Waugh MC. Functional outcomes of intramuscular botulinum toxin type a and occupational therapy in the upper limbs of children with cerebral palsy: a randomized controlled trial. Arch Phys Med Rehabil 2007, 88:1-10.
6. Law M, Baptiste S, Carswell A, McColl MA, Polatajko H, Pollock N. COPM: Canadian Occupational Performance Measure 2005, 4th edn, Ottawa, ON, Canada, Canadian Association of Occupational Therapists
7. DeMatteo C, Law M, Russell D, Pollock N, Rosenbaum P, Walter S. QUEST: Quality of Upper Extremity Skills Test 1992, Hamilton, ON, Canada, McMaster University Neurodevelopmental Clinical Research Unit
8. Huang W, Foster JA, Rogachefsky AS. Pharmacology of botulinum toxin. J Am Acad Dermatol 2000, 43:249-59.
9. Chin TYP, Nattrass GR, Selber P, Graham HK. Accuracy of intramuscular injection of botulinum toxin A in juvenile cerebral palsy: a comparison between manual needle placement and placement guided by electrical stimulation. J Pediatr Orthop 2005, 25:286-91.
10. Chin TYP, Duncan JA, Johnstone BR, Graham HK. Management of the upper limb in cerebral palsy. J Pediatr Orthop B 2005, 14:389-404.
11. Corry IS, Cosgrove AP, Walsh EG, McClean D, Graham HK. Botulinum toxin A in the hemiplegic upper limb: a double-blind trial. Dev Med Child Neurol 1997, 39:185-93.
12. Mastos M, Miller K, Eliasson AC, Imms C. Goal-directed training: linking theories of treatment to clinical practice for improved functional activities in daily life. Clin Rehabil 2007, 21:47-55.
13. Valvano J. Activity-focused motor interventions for children with neurological conditions. Phys Occup Ther Pediatr 2004, 24:79-107.
14. Carswell A, McColl MA, Baptiste S, Law M, Polatajko H, Pollock N. The Canadian Occupational Performance Measure: a research and clinical literature review. Can J Occup Ther 2004, 71:210-22.
15. Cusick A, Lannin NA, Lowe K. Adapting the Canadian Occupational Performance Measure for use in a paediatric clinical trial. Disabil Rehabil 2007, 29:761-66.
16. Verkerk GJ, Wolf MJ, Louwers AM, Meester-Delver A, Nollet F. The reproducibility and validity of the Canadian Occupational Performance Measure in parents of children with disabilities. Clin Rehabil 2006, 20:980-88.
17. Kiresuk TJ, Smith A, Cardillo JE. Goal Attainment Scaling: Applications, Theory, and Measurement 1994, Hillsdale, NJ, USA, Lawrence Erlbaum Associates
18. Boyd RN, Graham HK. Objective measurement of clinical findings in the use of botulinum toxin type A for the management of children with cerebral palsy. Eur J Neurol 1999, 6(Suppl. 4):S23-35.
19. Mackey AH, Walt SE, Lobb G, Stott NS. Intraobserver reliability of the modified Tardieu scale in the upper limb of children with hemiplegia. Dev Med Child Neurol 2004, 46:267-72.
20. Fehlings D, Rang M, Glazier J, Steele C. Botulinum toxin type A injections in the spastic upper extremity of children with hemiplegia: child characteristics that predict a positive outcome. Eur J Neurol 2001, 8(Suppl. 5):145-49.
21. Sterne JA, Davey Smith G. Sifting the evidence - what's wrong with significance tests. BMJ 2001, 322:226-31.
22. International Classification of Functioning, Disability and Health (ICF): ICF Children and Youth Version. http://www.who.int/classifications/icf/, (accessed May 2009)
23. Lowe K, Novak I, Cusick A. Repeat injection of botulinum toxin A is safe and effective for upper limb movement and function in children with cerebral palsy. Dev Med Child Neurol 2007, 49:823-29.
24. Wallen MA, O'Flaherty SJ, Waugh MC. Functional outcomes of intramuscular botulinum toxin type A in the upper limbs of children with cerebral palsy: a phase II trial. Arch Phys Med Rehabil 2004, 85:192-200.
25. Krumlinde-Sundholm L, Eliasson AC. Development of the Assisting Hand Assessment: a Rasch-built measure intended for children with unilateral upper limb impairments. Scand J Occup Ther 2003, 10:16-26.
26. Eliasson A-C, Krumlinde-Sundholm L, Rösblad B. The Manual Ability Classification System (MACS) for children with cerebral palsy: scale development and evidence of validity and reliability. Dev Med Child Neurol 2006, 48:549-54.
27. Hurvitz EA, Conti GE, Brown SH. Changes in movement characteristics of the spastic upper extremity after botulinum toxin injection. Arch Phys Med Rehabil 2003, 84:444-54.
28. Russo RN, Crotty M, Miller MD, Murchland S, Flett P, Haan E. Upper-limb botulinum toxin A injection and occupational therapy in children with hemiplegic cerebral palsy identified from a population register: a single-blind, randomized, controlled trial. Pediatrics 2007, 119:e1149-58.
29. Speth LA, Leffers P, Janssen-Potten YJ, Vles JS. Botulinum toxin A and upper limb functional skills in hemiparetic cerebral palsy: a randomized trial in children receiving intensive therapy. Dev Med Child Neurol 2005, 47:468-73.
30. Kawamura A, Campbell K, Lam-Damji S, Fehlings D. A randomized controlled trial comparing botulinum toxin A dosage in the upper extremity of children with spasticity. Dev Med Child Neurol 2007, 49:331-37.
31. Berweck S, Feldkamp A, Francke A, Nehles J, Schwerin A, Heinen F. Sonography-guided injection of botulinum toxin A in children with cerebral palsy. Neuropediatrics 2002, 33:221-23.